» Articles » PMID: 21704308

Glial Cell Response and INOS Expression in the Optic Nerve Head and Retina of the Rat Following Acute High IOP Ischemia-reperfusion

Overview
Journal Brain Res
Specialty Neurology
Date 2011 Jun 28
PMID 21704308
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Acute high IOP ischemia-reperfusion induces the loss of retinal ganglion cells, supporting the hypothesis that the condition of ischemia-reperfusion contributes to the induction and progression of glaucoma. This study investigated morphological changes, glial cell response, and expression of inducible nitric oxide synthase (iNOS) in the optic nerve head and retina of the rat following acute high IOP ischemia-reperfusion. A 60-min ischemic period was administered to the rat eye by raising the IOP, followed by a reperfusion period lasting 2, 5, or 7 days. Histological examination showed that acute high IOP ischemia-reperfusion injury produced optic nerve head and retina damage. In immunohistochemical staining, GFAP and OX-45 were limited to the ganglion cell layer (GCL) or inner nuclear layer (INL) of the control retina and increased to nearly all layers of the retina after acute high IOP ischemia-reperfusion. GFAP and OX-42 were detected at the control optic nerve heads and increased after acute high IOP ischemia-reperfusion. After acute high IOP ischemia-reperfusion, expression of iNOS increased, mostly at the GCL and INL of the retina and at the optic nerve head. Western blot analysis showed that expression of iNOS increased significantly, compared with the control, in the retina and optic nerve head after acute high IOP ischemia-reperfusion. Activation of glial cells and the up-regulation of iNOS may contribute to the damage of the retina and optic nerve head of the rat following acute high IOP ischemia-reperfusion.

Citing Articles

Mechanisms of retinal ganglion cell injury following acute increases in intraocular pressure.

Garner M, Strickland R, Girkin C, Gross A Front Ophthalmol (Lausanne). 2024; 2:1007103.

PMID: 38983517 PMC: 11182138. DOI: 10.3389/fopht.2022.1007103.


Cilastatin as a Potential Anti-Inflammatory and Neuroprotective Treatment in the Management of Glaucoma.

Martinez-Lopez M, Rubio-Casado S, San Felipe D, Martin-Sanchez B, Fernandez-Albarral J, Salobrar-Garcia E Int J Mol Sci. 2024; 25(6).

PMID: 38542089 PMC: 10970106. DOI: 10.3390/ijms25063115.


Effect of Muslim Prayer (Salat) positions on the intra-ocular pressure in healthy young individuals.

Aldossary N, Alnafjan D, Alharbi M, Aldahlawi N, Aldarwesh A Indian J Ophthalmol. 2023; 71(6):2495-2499.

PMID: 37322669 PMC: 10417953. DOI: 10.4103/IJO.IJO_2565_22.


Degeneration of retina-brain components and connections in glaucoma: Disease causation and treatment options for eyesight preservation.

Sharif N Curr Res Neurobiol. 2023; 3:100037.

PMID: 36685768 PMC: 9846481. DOI: 10.1016/j.crneur.2022.100037.


Impairments of retinal hemodynamics and oxygen metrics in ocular hypertension-induced ischemia-reperfusion.

Rahimi M, Leahy S, Matei N, Burford J, Blair N, Shahidi M Exp Eye Res. 2022; 225:109278.

PMID: 36252653 PMC: 10985794. DOI: 10.1016/j.exer.2022.109278.